LumiraDx Reports Second Quarter 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced
UrSure: Testing Adherence to Prevent HIV
People living with HIV, or human immunodeficiency virus, are at an increased risk for developing mood, anxiety, and cognitive disorders. They are also more likely to be diagnosed with depression than people who do not have HIV. According to the CDC, while new HIV diagnoses have decreased in recent years, approximately 1.7 million people around the world and 40,000 people in the US still become newly infected with HIV each year.
In 2013, Drs. Helen Koenig and Giffin Daughtridge started a clinic at the Philadelphia FIGHT Community Health Centers to provide PrEP (pre-exposure prophylaxis) medication to young black men who have sex with men who were at high risk of HIV infection. PrEP is intended for people at risk for HIV, and it is highly effective for preventing HIV from sex or injection drug use. PrEP needs to be taken daily and is much less effective when it is not taken consistently. Despite the drug being 99% effective at preventing HIV
Op-ed by OraSure Technologies: HIV testing access for Black Americans must dramatically improve, and self-testing is a critical tool to achieve this goal.